our Human Resources policy

RESOURCES

Circle Oncodesign Services

The process of discovery and development of a molecule is complex, long and costly. Before making a decision on the offer that best meets your needs, we offer online scientific resources and our latest news to help you get to know us better. Our experts are also at your disposal to help and support you in your research and development program.

Filter by category
  • All
  • Blog
  • Congress
  • Scientific resource
  • Webinar
  • Poster
  • Scientific publication
  • Press release
  • Press coverage
  • News
Filter by category
Circle Oncodesign Services
Oncodesign Your Ideal Partner in Drug Discovery
Scientific resource
12/06/2025

Endometriosis models – research strategies

Ready to advance your endometriosis preclinical development? Download the technical sheet and discover how we help your team move your program.

Scientific resource
12/06/2025

Rethinking Progress in Endometriosis Treatment

Read the white paper to learn: - Why endometriosis remains difficult to diagnose and treat - How new models are replicating human disease

Abstract render of glowing blue cells in microscopic view
Blog
10/06/2025

What Can Engineered Cells Tell You About Your Compound?

From signaling to surprises, reporter cell assays bring clarity to compound screening. Read the blog to find out what engineered cells can tell you.

Imaging a non invasive technique to follow your preclinical program
Scientific resource
05/06/2025

Unlock the Full Potential of Cancer Drugs with MRT [Download]

Explore how MRT can extend drug value & enable targeted therapy. Download our technical sheet to learn more.

Poster scientifique | Oncodesign Services
Poster
30/04/2025

TEQ103, a novel therapeutic for the treatment of breast cancer

These results demonstrate the significant durable antitumor effect of TEQ103 driven by the total dose administered. Read the poster!

Poster scientifique | Oncodesign Services
Poster
30/04/2025

MTL-004, a promising new therapeutic for post-resection treatment of glioblastoma

MTL-004 was found to be safe and well-tolerated at a dose of 1 mg/kg, and was excreted mainly through urine. Read the poster!

Poster scientifique | Oncodesign Services
Poster
29/04/2025

Metastasis Development Induced by Intracarotid Injection

We show a new TNBC mouse model of brain metastasis, induced by intracarotid injection, while assessing BBB integrity. Read the poster!

Poster scientifique | Oncodesign Services
Poster
28/04/2025

Novel PSMA+ and FAP+ mouse models

We designed new mouse models, which could aid in the development of novel imaging or radiotherapy agents for two biomarkers. Read the poster!

Poster scientifique | Oncodesign Services
Poster
28/04/2025

Pharmacological evaluation using the AbYlink TM regio-selective conjugation technology

AbYlink is a regio-selective labeling method, enabling a one-step conjugation of payloads to the Fc domain of an antibody. Read the poster!

Poster scientifique | Oncodesign Services
Poster
28/04/2025

PDX-Derived Organoids: Insights into Cancer Stem Cells and Metastasis

Our study highlights the versatility and translational relevance of PDXOs in cancer research. Read the poster!

News
24/04/2025

Debiopharm and Oncodesign Services Launch Strategic Collaboration

Debiopharm and Oncodesign Services announce the execution of a license agreement for the use of the AbYlink technology

Representing radioligand binding assays (RLBA), an assay plate in neon pink.
Blog
23/04/2025

Radioligand Binding Assays: A Lost Art in Drug Discovery?

Old-school or still essential? Explore the overlooked power of radioligand binding assays in today's research environment.